Nanomedicine: an emerging era of theranostics and therapeutics for rheumatoid arthritis

Rheumatology
Naila QamarPeter John

Abstract

RA is a multifactorial autoimmune inflammatory disease characterized by synovitis, bone destruction and joint dysfunction that leads to shortening of lifespan and increased mortality rates. Currently available treatments of RA, by controlling various symptoms, only delay disease progression and have their own side effects. Consequently, there is the need for a novel therapeutic strategy that offers a more sustainable and biocompatible solution. Nanomedicine is a modern branch of nanobiotechnology that provides targeted therapy to inflamed rheumatic joints and thus prevents unwanted off-target side effects. This review highlights various nanotheranostic and nanotherapeutic strategies that are currently being used for the treatment of RA.

References

May 16, 2003·Nature·Gary S Firestein
Jun 14, 2005·Journal of Clinical Pharmacology·Tanya Doan, Elena Massarotti
Feb 27, 2009·The Journal of Pharmacology and Experimental Therapeutics·Tsutomu IshiharaMegumu Higaki
May 28, 2011·Arthritis and Rheumatism·Thommey P ThomasJames R Baker
Aug 13, 2011·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Christine T N Pham
May 30, 2012·Nanomedicine : Nanotechnology, Biology, and Medicine·Israel Rubinstein, Guy L Weinberg
Jun 26, 2012·Advanced Drug Delivery Reviews·Simona Mura, Patrick Couvreur
Dec 6, 2012·Molecular Pharmaceutics·Varun SethiHayat Onyuksel
Oct 23, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·So Jin LeeKwangmeyung Kim
Dec 7, 2013·Biotechnology Advances·Juan LiuXing-Jie Liang
Apr 2, 2014·TheScientificWorldJournal·Bhupinder KapoorYogyata Vaidya
Aug 27, 2014·The Journal of Clinical Investigation·Hui-fang ZhouChristine T N Pham
Jun 19, 2015·Nanomedicine·Leena Kumari PrasadZhengrong Cui
Jan 7, 2016·Nanomedicine : Nanotechnology, Biology, and Medicine·Eugénia NogueiraArtur Cavaco-Paulo
May 3, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Sanam DolatiMehdi Yousefi
May 28, 2016·Experimental Biology and Medicine·Terrika A Ngobili, Michael A Daniele
Jun 11, 2016·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Maria Fernanda Hornos Carneiro, Fernando Barbosa
Jan 18, 2017·Current Topics in Medicinal Chemistry·Mahfoozur RahmanSohail Akhter
Nov 3, 2015·Nanomaterials·Pedro PedrosaPedro V Baptista
Jul 8, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Zahid HussainFahad Hussain
Aug 30, 2017·Expert Opinion on Drug Delivery·Minglei ChenLi Zong
Jan 10, 2018·Frontiers in Cardiovascular Medicine·Shunsuke KatsukiKensuke Egashira
Jan 23, 2018·Bioconjugate Chemistry·Yao JiangLiangfang Zhang
Sep 21, 2018·Journal of Nanobiotechnology·Jayanta Kumar PatraHan-Seung Shin

❮ Previous
Next ❯

Citations

Aug 6, 2020·Frontiers in Bioengineering and Biotechnology·Pingping WangDi Xu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

Journal of Controlled Release : Official Journal of the Controlled Release Society
Shuyi XiaoLiang Chen
Artificial Cells, Nanomedicine, and Biotechnology
Sana Pirmardvand CheginiSomayeh Taymouri
Pakistan Journal of Pharmaceutical Sciences
Syed Fazal JalilPeter John
© 2021 Meta ULC. All rights reserved